S.C. Gad, Gad Consulting Services, USA
Evaluation of biocompatability of medical devices and biomaterials to meet regulatory requirement starts with consideration of the ISO-10993 guidance (as currently revised) and relevant local expectations such as the FDA G-95 Memorandum requirements. All of these require one to consider the type and duration of potential patient exposure, then to conduct required testing, and finally to do an integrated risk assessment based on the data collected. This chapter seeks to summarize that effort.
foreign body response